Back to search

Article

Clinical Efficacy of Macrolide Antibiotics in Mycoplasma Pneumoniae Pneumonia Carrying a Macrolide-resistant Mutation in the 23S rRNA Gene in Pediatric Patients

2024-05-23

Abstract excerpt

<title>Abstract</title><p>Background. These global prospective surveillance data showed the re-emergence of mycoplasma pneumoniae pneumonia (MPP) in Europe and Asia after the coronavirus disease 2019 pandemic. We sought to observe the effect of macrolide antibiotics in the treatment of MPP carrying a macrolide-resistant mutation gene and the potential of targeted next-generation sequencing (tNGS) as a front-line d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
058b5844-bb05-5cd8-9ee5-d6a60bdf6e1f
DOI
10.21203/rs.3.rs-4376915/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical Efficacy of Macrolide Antibiotics in Mycoplasma Pneumoniae Pneumonia Carrying a Macrolide-resistant Mutation in the 23S rRNA Gene in Pediatric PatientsDOI 10.21203/rs.3.rs-4376915/v1
Clinical efficacy of macrolide antibiotics in mycoplasma pneumoniae pneumonia carrying a macrolide-resistant mutation in the 23 S rRNA gene in pediatric patients.Semantic proximity
Association analysis of Mycoplasma pneumoniae 23S rRNA gene mutation with refractory Mycoplasma pneumoniae pneumonia in children.Semantic proximity
Correlation Analysis of DNA Load, Drug-resistant Mutations and Clinical Manifestation of Mycoplasma pneumoniae Infection in ChildrenSemantic proximity
Macrolide resistance and risk factors for refractory Mycoplasma pneumoniae pneumonia in pediatric patients from Wuhu, China: A retrospective cohort study.Semantic proximity
Epidemiology and high-level macrolide resistance of Mycoplasma pneumoniae among children in Hangzhou, China: a 2024–2025 single-center surveillance studySemantic proximity
Comparative analysis of clinical characteristics of drug-resistant Mycoplasma pneumoniae pneumonia and viral pneumonia in children under 6 years of ageSemantic proximity
Doxycycline for Macrolide-Resistant<em> Mycoplasma pneumoniae</em> Pneumonia in Children: Analysis of Efficacy and Safety Across Different Age GroupsSemantic proximity
Molecular epidemiology and genomic characterization of postpandemic macrolide-resistant Mycoplasma pneumoniae in hospitalized children.Semantic proximity
[Epidemic characteristics of mycoplasma pneumoniae infection and drug-resistant gene mutations in hospitalized children aged 0-17 in Ningbo City from 2019 to 2023].Semantic proximity
Prediction Model for Severe Mycoplasma pneumoniae Pneumonia: Treatment Guidance for Pediatric A2063/2064G-mutated InfectionsSemantic proximity
[Analysis of multidrug resistance gene locus mutations and clinical significance in children with Mycoplasma pneumoniae pneumonia].Semantic proximity
The impact of non-pharmaceutical interventions on the epidemiological characteristics and macrolide resistance of Mycoplasma pneumoniae infection in children during COVID-19 in single centre.Semantic proximity
Select a neighboring publication to make it the new centre.